Literature DB >> 9672167

Correlation between virus genotype and chronicity rate in acute hepatitis C.

P Amoroso1, M Rapicetta, M E Tosti, A Mele, E Spada, S Buonocore, G Lettieri, P Pierri, P Chionne, A R Ciccaglione, L Sagliocca.   

Abstract

BACKGROUND/AIMS: Forty-two patients with the diagnosis of acute hepatitis C virus hepatitis were studied to investigate the relationship between hepatitis C virus genotype and progression to chronic infection.
METHODS: The patients were followed for more than 1 year (mean age 29 years, male/female ratio 2.5). Intravenous drug use was documented in 15 cases, blood transfusion in four, surgical intervention, dental therapy or other parenteral exposure in 15, and unknown factors in the remaining eight. The evolution to chronicity was diagnosed on the basis of a persistent increase in transaminase levels, the presence of HCV-RNA and the histological pattern of chronic hepatitis.
RESULTS: The majority of cases presented hepatitis C virus infection of subtype 1a (38.1%) or 1b (33.9%). Six cases showed the presence of genotype 3a (14.3%). Subtype 2c was observed in three out of four cases infected with genotype 2. No significant association was demonstrated with documented risk factors. The overall chronicity rate was 59.5%. This value increased to 92% in individuals infected with genotype 1b. By multivariate analysis the age-adjusted odds ratio for infection with genotype 1b as compared with all other genotypes was 14.4 (95% confidence interval; 1.52-137). Moreover, significant differences (p= 0.0002) were present in this group for histological activity index (8.7 as compared with 5-7).
CONCLUSIONS: The results of this prospective study are consistent with an independent association between hepatitis C virus genotype 1b and a poor prognosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9672167     DOI: 10.1016/s0168-8278(98)80340-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  32 in total

Review 1.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

2.  GB virus C/hepatitis G virus groups and subgroups: classification by a restriction fragment length polymorphism method based on phylogenetic analysis of the 5' untranslated region.

Authors:  J F Quarleri; V L Mathet; M Feld; D Ferrario; M P della Latta; R Verdun; D O Sánchez; J R Oubiña
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

3.  Molecular characterization of a full genome Turkish hepatitis C virus 1b isolate (HCV-TR1): a predominant viral form in Turkey.

Authors:  Esra Yildiz; Asli Oztan; Funda Sar; Ergun Pinarbasi; Rengul Cetin-Atalay; Hikmet Akkiz; Mehmet Ozturk
Journal:  Virus Genes       Date:  2002-10       Impact factor: 2.332

4.  Impact of host responses on control of hepatitis C virus infection in Chinese blood donors.

Authors:  Tingting Li; Zixuan Chen; Jinfeng Zeng; Jingang Zhang; Wenjing Wang; Ling Zhang; Xin Zheng; Lifang Shuai; Paul Klenerman; Jean-Pierre Allain; Chengyao Li
Journal:  Biochem Biophys Res Commun       Date:  2011-10-29       Impact factor: 3.575

5.  Natural evolution of hepatitis C virus infection in hemodialysis Tunisian patients and CTLA-4 SNP's.

Authors:  Leila Ksiaa Cheikhrouhou; Yousr Lakhoua-Gorgi; Imen Sfar; Salwa Jendoubi-Ayed; Houda Aouadi; Mouna Makhlouf; Khaled Ayed; Taieb Ben Abdallah
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

6.  Nested restriction site-specific PCR to detect and type hepatitis C virus (HCV): a rapid method to distinguish HCV subtype 1b from other genotypes.

Authors:  L Krekulova; V Rehak; A E Wakil; E Harris; L W Riley
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

7.  Genotype-related variations in proinflammatory and regulatory cytokine levels in treated and treatment-naive HCV-infected patients.

Authors:  Rasoul Baharlou; Bizhan Romani; Seyed Jalal Kiani; Kaveh Sadeghi; Enayatollah Shadmand; Hadi Fazel; Farid Azizi Jalilian; Ebrahim Kord; Sajad Yaghoubi; Yousef Nikmanesh; Abbas Ahmadi Vasmehjani
Journal:  Med Microbiol Immunol       Date:  2017-11-17       Impact factor: 3.402

8.  HCV-specific immune responses induced by CIGB-230 in combination with IFN-α plus ribavirin.

Authors:  Yalena Amador-Cañizares; Gillian Martínez-Donato; Liz Alvarez-Lajonchere; Claudia Vasallo; Mariacarla Dausá; Daylen Aguilar-Noriega; Carmen Valenzuela; Ivette Raíces; Jean Dubuisson; Czeslaw Wychowski; Zurina Cinza-Estévez; Marlén Castellanos; Magdalys Núñez; Anny Armas; Yaimé González; Ismariley Revé; Ivis Guerra; Angel Pérez Aguiar; Santiago Dueñas-Carrera
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

9.  Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients.

Authors:  E Riva; F Maggi; F Abbruzzese; F Bellomi; G Giannelli; A Picardi; C Scagnolari; A Folgori; E Spada; E Piccolella; F Dianzani; G Antonelli
Journal:  Med Microbiol Immunol       Date:  2008-08-12       Impact factor: 3.402

10.  Most common genotypes and risk factors for HCV in Gaza strip: a cross sectional study.

Authors:  Basim M Ayesh; Sofia S Zourob; Salah Y Abu-Jadallah; Yonat Shemer-Avni
Journal:  Virol J       Date:  2009-07-16       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.